Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Takeda addressing Gammagard Liquid supplies but says it will take time
Takeda addressing Gammagard Liquid supplies but says it will take time
This $1 billion, 1-million-square-foot plasma fractionation plant in Georgia has gone through four owners already since it was envisioned.
Artificial intelligence is selecting grant reviewers in China
Artificial intelligence is selecting grant reviewers in China
China’s largest funder of basic science is piloting an artificial intelligence tool that selects researchers to review grant applications, in an attempt to make the process more efficient, faster an...
FDA approval for Bavencio combo in advanced RCC
FDA approval for Bavencio combo in advanced RCC
The US Food and Drug Administration (FDA) has approved Merck's Bavencio (avelumab) plus Inlyta (axitinib) combination for patients with advanced renal cell carcinoma.
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy
FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy
Regeneron Pharmaceuticals, Inc.
Disappointing Nerlynx sales shows Pierre Fabre timing is everything
Disappointing Nerlynx sales shows Pierre Fabre timing is everything
Caveat emptor.
Roche pushes back Spark tender a third time. Will it close the deal on time — or ever?
Roche pushes back Spark tender a third time. Will it close the deal on time — or ever?
Roche has said a delay in the U.
FDA finds testing issues at Torrent plant
FDA finds testing issues at Torrent plant
A year after Torrent Pharmaceuticals first began recalling tainted losartan products manufactured at its Indrad plant, the FDA paid a visit.
California jury hits Bayer with $2 billion award in Roundup cancer trial
California jury hits Bayer with $2 billion award in Roundup cancer trial
(Reuters) - A California jury on Monday awarded more than $2 billion to a couple who claimed Bayer AG’s glyphosate-based Roundup weed killer caused their cancer, in the largest U.
NHS to tackle elderly over-medication with 200 new pharmacists
NHS to tackle elderly over-medication with 200 new pharmacists
The NHS has announced plans to recruit an ‘army’ of experts to tackle over-medication in care homes, with many already in place.
What you need to know about the U.S. measles outbreak
What you need to know about the U.S. measles outbreak
(Reuters) - The United States so far this year has recorded 839 cases of measles in 23 states, its largest outbreak since public health officials in 2000 declared the disease eradicated, the C...
3M’s $6.725 Billion Acquisition Of Acelity And Its KCI Subsidiaries
3M’s $6.725 Billion Acquisition Of Acelity And Its KCI Subsidiaries
Simpson Thacher represented a consortium comprised of funds advised by Apax Partners (the “Apax Funds”), together with Canada Pension Plan Investment Board (“CPPIB”) and the Pu...
Novartis buys dry eye drug from Takeda for up to $5.3 billion
Novartis buys dry eye drug from Takeda for up to $5.3 billion
TOKYO/ZURICH (Reuters) - Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to $5.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand